MO19391: An open-label safety study of bevacizumab plus taxane-based therapy as first-line treatment of patients with locally recurrent (LR) or metastatic breast cancer (MBC) Conference Paper uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Pierga, J
  • Pritchard, Kathleen
  • Cortes-Funes, H
  • Biganzoli, L
  • Thomssen, C
  • Franke, FA
  • Smith, IE
  • Bogdanova, N
  • Stroyakovskiy, D

publication date

  • May 20, 2008